About 40 Maryland life sciences organizations are working on creating and assembling COVID-19 vaccines and therapeutics, improving diagnostic tests, and giving clinical examination and technical support to guarantee safe and viable health care delivery.

The University System of Maryland and Johns Hopkins University have likewise committed a great many dollars toward examination, testing, and clinical preliminaries. The University of Maryland School of Medicine recently started stage three testing of a COVID-19 immunization.

Up to now, Maryland’s life sciences companies have secured more than $3 billion for the advancement of a vaccine for SARS-CoV-2, the infection that causes COVID-19.

READ FULL ARTICLE HERE